We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
China's National Centre for Adverse Drug Reaction (ADR) Monitoring has announced that it received a total of 36,377 ADR case reports in the first six months of 2005.
A controversial bill that the State Duma is set to pass after it reconvenes next month would prohibit doctors from prescribing specific, brand-name drugs.
ImmunoGen, Inc. (Nasdaq: IMGN) today announced that Aventis Pharmaceuticals Inc. of the sanofi-aventis Group has exercised its right to extend the term of its research collaboration with the Company and committed to fund ImmunoGen $18.2 million in research support over the twelve months beginning September 1, 2006.
A survey showing support for an independent review of government medicine funding agency Pharmac has been backed by the Researched Medicines Industry Association (RMI).
Merck KGaA said it has submitted an application to the European Medicines Agency (EMEA) and Swissmedic to extend the use of cancer drug Erbitux to treat head and neck cancer in combination with radiation therapy.